Nexstim Gives an Update on its Promising Treatment Results of Major Depressive Disorder
Press Release, Helsinki, 12 March 2021 at 10.00 (EET) Nexstim Gives an Update on its Promising Treatment Results of Major...
Month: March 2021
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
COPENHAGEN, Denmark, March 12, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) has today received information about the following...
Aino Health AB (publ): Wihuri Oy expands the usage of the SaaS solution Aino HealthManager to all of Finland
Stockholm 12 March 2021: Aino Health announces today that Wihuri Oy has decided to expand the use of Aino's solutions to...
Bavarian Nordic Publishes Annual Report 2020
COPENHAGEN, Denmark, March 12, 2021 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today published its Annual Report for 2020....
Exercise of Options and Total Voting Rights
Exercise of Options and Total Voting Rights DUBLIN, Ireland, and Boston MA, March 12, 2021, Amryt (Nasdaq: AMYT, AIM: AMYT),...
Annual General Meeting’s results and cash information to serve the development strategy
Press release Ecully, 12 March 2021 – 8 a.m. Approval of the General Meeting’s resolutionsSolid cash position to continue development...
Sanofi and Translate Bio initiate Phase 1/2 clinical trial of mRNA COVID-19 vaccine candidate
Sanofi and Translate Bio initiate Phase 1/2 clinical trial of mRNA COVID-19 vaccine candidate Clinical trial to assess safety, immune...
Altimmune Expands AdCOVID™ Manufacturing Collaboration with Lonza
Lonza to Commission a Dedicated Suite for Clinical and Commercial Supply of Altimmune’s COVID-19 Vaccine Candidate at its Houston FacilityGAITHERSBURG,...
Sanofi and Translate Bio Initiate Phase 1/2 Clinical Trial of mRNA COVID-19 Vaccine Candidate
-- Clinical trial to assess safety, immune response and reactogenicity, after preclinical data showed high neutralizing antibody levels -- --...
Longboard Pharmaceuticals Announces Pricing of Initial Public Offering
SAN DIEGO, March 11, 2021 (GLOBE NEWSWIRE) -- Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing novel, transformative...
EssilorLuxottica: Full year 2020 results // Resilience, digitalization and synergies lead to strong recovery and solid foundations for the future
Full year 2020 results Resilience, digitalization and synergies lead to strong recovery and solid foundations for the future Swift reaction...
Nova Leap Health Corp. Reports Fourth Quarter and Full Year 2020 Financial Results
Nova Leap Health's Annual Revenue Nova Leap Health's Annual Revenue Nova Leap Health's Annual EBITDA Nova Leap Health's Annual EBITDA...
Reviva Pharmaceuticals Holdings, Inc. to Present at the Maxim Group Inaugural 2021 Emerging Growth Virtual Conference
CUPERTINO, Calif., March 11, 2021 (GLOBE NEWSWIRE) -- Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) (along with its subsidiaries, “Reviva” or...
UPDATE: Foghorn Therapeutics to Present Poster and Chair a Panel at the AACR Annual Meeting 2021
CAMBRIDGE, Mass., March 11, 2021 (GLOBE NEWSWIRE) -- Foghorn Therapeutics Inc. (Nasdaq: FHTX), a company pioneering the discovery and development...
PLx Pharma Inc. to Present at the Oppenheimer 31st Annual Healthcare Conference
SPARTA, N.J., March 11, 2021 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a specialty pharmaceutical...
DBV Technologies Reports Full-Year 2020 Financial Results and Recent Business Developments
Montrouge, France, March 11, 2021 DBV Technologies Reports Full-Year 2020 Financial Results and Recent Business Developments DBV Technologies S.A. (Euronext:...
Family of Bob Marley and Silo Wellness Collaborate to Debut Exclusive Worldwide Functional & Psychedelic Mushroom Brand
MONTEGO BAY, Jamaica, March 11, 2021 (GLOBE NEWSWIRE) -- Silo Wellness Inc. (“Silo Wellness” or the “Company”) (CSE: SILO), a...
KemPharm Reports Fourth Quarter and Full-Year 2020 Financial Results
Corporate and Regulatory Highlights: AZSTARYS™ NDA approved by the FDA on March 2, 2021Co-hosted “KP415 Market Opportunity and Commercialization Strategy” Investor...
Neuronetics Announces Retirement of Gregory Harper, Vice President, R&D and Clinical
MALVERN, Pa., March 11, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on...
Entera Bio to Report Financial Results for the Year Ended December 31, 2020 on March 18, 2021
BOSTON and JERUSALEM, March 11, 2021 (GLOBE NEWSWIRE) -- Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of...